124 related articles for article (PubMed ID: 4043177)
41. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
Stacher A; Heinz R; Waldner R; Böhnel J
Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
[TBL] [Abstract][Full Text] [Related]
42. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
Byrne GE
Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
[TBL] [Abstract][Full Text] [Related]
43. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
[TBL] [Abstract][Full Text] [Related]
44. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
[TBL] [Abstract][Full Text] [Related]
45. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.
Gerdes J; Dallenbach F; Lennert K; Lemke H; Stein H
Hematol Oncol; 1984; 2(4):365-71. PubMed ID: 6396192
[TBL] [Abstract][Full Text] [Related]
46. Primary non-Hodgkin's lymphomas of the female breast.
Giardini R; Piccolo C; Rilke F
Cancer; 1992 Feb; 69(3):725-35. PubMed ID: 1730123
[TBL] [Abstract][Full Text] [Related]
47. Modification of Kiel and working formulation classifications for improved survival prediction in non-Hodgkin's lymphoma.
Nabholtz JM; Friedman S; Collin F; Guerrin J
J Clin Oncol; 1987 Oct; 5(10):1634-9. PubMed ID: 3655861
[TBL] [Abstract][Full Text] [Related]
48. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
49. Serum lactate dehydrogenase isoenzyme pattern in non-Hodgkin's lymphomas.
Ricerca BM; Storti S; Campisi S; Pagano L; Dalla Torre F; Marra R; Amato A; Mango G; Bizzi B
Int J Biol Markers; 1988; 3(4):237-42. PubMed ID: 3235851
[TBL] [Abstract][Full Text] [Related]
50. [Adenosine deaminase activity in Hodgkin's disease (author's transl)].
Müller G; Krug K; Krüger W; Richter V; Rassoul F
Klin Wochenschr; 1982 Mar; 60(6):317-8. PubMed ID: 7078027
[TBL] [Abstract][Full Text] [Related]
51. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
52. Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival.
Krol AD; Hermans J; Kramer MH; Kluin PM; Kluin-Nelemans HC; Blok P; Heering KJ; Noordijk EM; van Krieken JH
Cancer; 1997 Jan; 79(2):390-7. PubMed ID: 9010113
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas.
Kovalevska LM; Yurchenko OV; Shlapatska LM; Berdova GG; Mikhalap SV; Van Lint J; Sidorenko SP
Exp Oncol; 2006 Sep; 28(3):225-30. PubMed ID: 17080017
[TBL] [Abstract][Full Text] [Related]
54. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
[TBL] [Abstract][Full Text] [Related]
55. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
[TBL] [Abstract][Full Text] [Related]
56. [Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas].
Brittinger G; Bartels H; Common H; Dühmke E; Engelhard M; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E
Onkologie; 1986 Apr; 9(2):118-25. PubMed ID: 3520420
[TBL] [Abstract][Full Text] [Related]
57. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
Teske E; Wisman P; Moore PF; van Heerde P
Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
[TBL] [Abstract][Full Text] [Related]
58. A quantitative study of alpha-naphthyl acetate esterase-positive cells in non-Hodgkin's lymphomas and reactive lymph nodes.
Crocker J; Jones EL; Curran RC
J Clin Pathol; 1982 Oct; 35(10):1066-8. PubMed ID: 7130417
[TBL] [Abstract][Full Text] [Related]
59. Pathological and immunophenotypic features of adult non-Hodgkin's lymphomas by age group.
Carbone A; Franceschi S; Gloghini A; Russo A; Gaidano G; Monfardini S
Hum Pathol; 1997 May; 28(5):580-7. PubMed ID: 9158706
[TBL] [Abstract][Full Text] [Related]
60. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
